Aurinia Pharmaceuticals, Inc. (AUPH)
13.95
-0.42
(-2.92%)
USD |
NASDAQ |
Mar 13, 16:00
13.95
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Max Drawdown (5Y) : 87.58% for Feb. 28, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Xenon Pharmaceuticals, Inc. | 43.59% |
| Oncolytics Biotech, Inc. | 92.83% |
| Edesa Biotech, Inc. | 99.04% |
| Lexaria Bioscience Corp. | 99.02% |
| ProMIS Neurosciences, Inc. | 97.95% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -19.75 |
| Beta (5Y) | 1.535 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 72.55% |
| Historical Sharpe Ratio (5Y) | -0.0427 |
| Historical Sortino (5Y) | -0.0856 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.95% |